2020 has certainly not been the year that any of us expected. From social distancing and enforced lockdown to virtual meetings and events and restricted travel, the pharmaceutical industry has had to adapt and be creative as it continues to operate and supply vital medicines to patients, while also supporting vaccine development for COVID-19.
In an article with CPhI Online, our chief commercial officer, Tony O’Sullivan discussed the changing face of operations in pharmaceutical manufacturing during the pandemic and how it has impacted the pharmaceutical supply chain.
Read the article here: https://bit.ly/3kYBBsE
